See more : Mogo Inc. (MOGO.TO) Income Statement Analysis – Financial Results
Complete financial analysis of The United Laboratories International Holdings Limited (3933.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The United Laboratories International Holdings Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Woodward, Inc. (WWD) Income Statement Analysis – Financial Results
- Vedanta Limited (VEDL.BO) Income Statement Analysis – Financial Results
- Legato Merger Corp. II (LGTO) Income Statement Analysis – Financial Results
- Francotyp-Postalia Holding AG (FPH.DE) Income Statement Analysis – Financial Results
- PayGroup Limited (PYG.AX) Income Statement Analysis – Financial Results
The United Laboratories International Holdings Limited (3933.HK)
About The United Laboratories International Holdings Limited
The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, nervous system drugs, vitamins, and vacant gelatin capsules, as well as API and intermediate products. It also manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, other Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.74B | 11.33B | 9.70B | 8.77B | 8.39B | 7.51B | 6.83B | 6.08B | 6.45B | 6.42B | 5.97B | 5.65B | 5.18B | 5.54B | 4.09B | 3.31B | 2.43B | 2.09B |
| Cost of Revenue | 7.41B | 6.37B | 5.49B | 4.97B | 4.77B | 4.46B | 4.33B | 3.92B | 3.97B | 3.84B | 3.91B | 3.95B | 3.70B | 3.35B | 2.49B | 2.05B | 1.30B | 1.35B |
| Gross Profit | 6.33B | 4.97B | 4.21B | 3.81B | 3.62B | 3.05B | 2.50B | 2.16B | 2.48B | 2.58B | 2.06B | 1.70B | 1.48B | 2.19B | 1.60B | 1.26B | 1.13B | 738.29M |
| Gross Profit Ratio | 46.11% | 43.84% | 43.40% | 43.39% | 43.15% | 40.64% | 36.60% | 35.58% | 38.48% | 40.20% | 34.49% | 30.15% | 28.55% | 39.49% | 39.07% | 38.06% | 46.47% | 35.39% |
| Research & Development | 757.25M | 593.60M | 465.24M | 352.28M | 398.54M | 313.47M | 171.97M | 77.17M | 61.33M | 118.06M | 108.17M | 73.23M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 789.86M | 703.35M | 698.34M | 742.00M | 740.65M | 646.83M | 596.75M | 608.73M | 614.63M | 575.12M | 434.17M | 475.31M | 372.47M | 306.74M | 256.72M | 217.98M | 162.32M | 123.29M |
| Selling & Marketing | 1.59B | 1.66B | 1.63B | 1.48B | 1.48B | 1.19B | 1.07B | 1.06B | 1.08B | 1.00B | 961.38M | 870.97M | 830.52M | 800.31M | 632.18M | 488.22M | 357.42M | 284.86M |
| SG&A | 2.38B | 2.35B | 2.33B | 2.22B | 2.22B | 1.84B | 1.67B | 1.67B | 1.70B | 1.58B | 1.40B | 1.35B | 1.20B | 1.11B | 888.91M | 706.20M | 519.74M | 408.15M |
| Other Expenses | 0.00 | 3.93M | -8.51M | 7.19M | 5.39M | 627.00K | -36.42M | -54.62M | -64.58M | -76.41M | -125.31M | -13.21M | 4.27M | 11.89M | 19.86M | -19.50M | 11.88M | 27.95M |
| Operating Expenses | 3.05B | 2.95B | 3.03B | 2.86B | 2.55B | 2.03B | 2.19B | 2.09B | 2.03B | 1.78B | 1.22B | 1.38B | 1.23B | 1.12B | 908.76M | 686.70M | 531.62M | 436.10M |
| Cost & Expenses | 10.55B | 9.32B | 8.52B | 7.82B | 7.32B | 6.49B | 6.52B | 6.00B | 5.99B | 5.62B | 5.13B | 5.33B | 4.93B | 4.47B | 3.40B | 2.73B | 1.83B | 1.78B |
| Interest Income | 105.42M | 10.86M | 22.55M | 68.49M | 229.68M | 224.26M | 240.38M | 214.63M | 256.24M | 272.14M | 137.38M | 15.89M | 9.42M | 4.91M | -0.84 | -0.05 | -0.21 | -5.90M |
| Interest Expense | 66.90M | 81.60M | 60.23M | 181.27M | 280.84M | 246.90M | 266.74M | 243.94M | 292.67M | 297.44M | 157.18M | 173.06M | 125.24M | 78.25M | 77.91M | 103.18M | 74.91M | 79.81M |
| Depreciation & Amortization | 565.65M | 552.43M | 620.86M | 614.47M | 675.73M | 747.62M | 789.78M | 744.07M | 681.77M | 565.82M | 445.04M | 434.77M | 367.87M | 357.19M | 298.05M | 222.91M | 174.82M | 194.52M |
| EBITDA | 3.98B | 2.54B | 1.98B | 1.83B | 1.61B | 1.63B | 1.36B | 1.04B | 1.18B | 1.40B | 857.38M | 762.42M | 641.38M | 1.42B | 986.44M | 794.99M | 772.78M | 496.71M |
| EBITDA Ratio | 28.94% | 22.40% | 20.38% | 20.83% | 19.18% | 21.77% | 19.86% | 17.16% | 20.16% | 20.89% | 14.36% | 13.49% | 12.46% | 25.75% | 24.13% | 24.04% | 31.79% | 23.81% |
| Operating Income | 3.29B | 2.02B | 1.38B | 1.23B | 1.02B | 903.03M | 578.61M | 332.72M | 617.84M | 776.10M | 412.34M | 327.64M | 278.00M | 1.07B | 688.39M | 572.07M | 597.96M | 302.19M |
| Operating Income Ratio | 23.94% | 17.78% | 14.24% | 14.03% | 12.14% | 12.02% | 8.48% | 5.47% | 9.58% | 12.08% | 6.90% | 5.80% | 5.36% | 19.30% | 16.84% | 17.30% | 24.60% | 14.49% |
| Total Other Income/Expenses | 54.83M | -18.31M | -208.75M | -349.21M | -245.28M | -218.99M | -698.55M | -550.68M | -607.76M | -356.80M | 107.81M | -125.92M | -102.64M | -78.25M | -77.91M | -103.18M | -74.91M | -79.81M |
| Income Before Tax | 3.34B | 2.01B | 1.20B | 882.33M | 841.65M | 793.88M | 68.95M | -137.47M | 197.22M | 530.72M | 703.76M | 199.94M | 148.26M | 991.38M | 610.48M | 468.90M | 523.05M | 222.38M |
| Income Before Tax Ratio | 24.34% | 17.71% | 12.39% | 10.06% | 10.03% | 10.57% | 1.01% | -2.26% | 3.06% | 8.26% | 11.78% | 3.54% | 2.86% | 17.89% | 14.93% | 14.18% | 21.52% | 10.66% |
| Income Tax Expense | 643.30M | 425.74M | 213.06M | 181.42M | 199.89M | 110.95M | 12.81M | 134.89M | 104.77M | 14.02M | 666.25M | 69.52M | 63.87M | 161.18M | 133.76M | 90.13M | 44.85M | 48.07M |
| Net Income | 2.70B | 1.58B | 988.10M | 702.99M | 641.76M | 682.93M | 81.76M | -272.36M | 92.41M | 544.62M | 37.54M | 130.42M | 84.39M | 830.20M | 476.71M | 378.77M | 478.20M | 174.31M |
| Net Income Ratio | 19.66% | 13.95% | 10.18% | 8.01% | 7.65% | 9.09% | 1.20% | -4.48% | 1.43% | 8.48% | 0.63% | 2.31% | 1.63% | 14.98% | 11.66% | 11.45% | 19.67% | 8.36% |
| EPS | 1.49 | 0.87 | 0.54 | 0.40 | 0.39 | 0.37 | 0.05 | -0.17 | 0.06 | 0.33 | 0.02 | 0.09 | 0.06 | 0.61 | 0.36 | 0.29 | 0.41 | 0.18 |
| EPS Diluted | 1.49 | 0.87 | 0.54 | 0.40 | 0.39 | 0.37 | 0.05 | -0.17 | 0.06 | 0.33 | 0.02 | 0.09 | 0.06 | 0.61 | 0.36 | 0.29 | 0.41 | 0.18 |
| Weighted Avg Shares Out | 1.82B | 1.82B | 1.84B | 1.77B | 1.64B | 1.83B | 1.63B | 1.63B | 1.63B | 1.63B | 1.63B | 1.51B | 1.42B | 1.36B | 1.31B | 1.31B | 1.16B | 980.87M |
| Weighted Avg Shares Out (Dil) | 1.82B | 1.82B | 1.84B | 1.77B | 1.64B | 1.83B | 1.63B | 1.63B | 1.63B | 1.63B | 1.63B | 1.51B | 1.42B | 1.36B | 1.31B | 1.31B | 1.16B | 980.87M |
Source: https://incomestatements.info
Category: Stock Reports